Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
This quick overview presents the typical long-term return profile of total market funds, helping frame diversified retirement and growth goals.
28,588 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Ripple accelerates its global push as it secures licenses and partnerships while the XRP ETF narrative gains traction...
GoMining unveils a base-layer Bitcoin payments protocol designed for instant settlements and everyday purchases, plus...
A small lithium technology firm surged to a $1B valuation after unveiling a breakthrough recovery method, signaling a...
As lawmakers push a sweeping crypto regulation bill, the former president's outspoken support for digital assets is c...
Senator Lummis frames Bitcoin as a hedge against mounting U.S. debt as the CLARITY Act moves closer to a Senate floor...
Allium, a crypto analytics startup, secures a $40 million Series B to scale its data platform for institutional clien...
Schwab strategists warn major shifts are underway as volatility rises and policy tightens, signaling an era change fo...
Tuesday brought a notable rally in Honeywell shares as the company outlined a stand-alone path for Quantinuum. This a...
Kyndryl’s latest quarterly results triggered a notable stock move as earnings fell short of expectations. This articl...
Cardano's governance changes are triggering uncertainty. This article explains why cardano's founder predicts hard ti...
Deals eyes turn to a potential pact between the U.S. and Iran over Tehran's nuclear program, with a signing anticipat...